BE901411A - Compose antiobiotique, procede pour le preparer et compositions le contenant. - Google Patents

Compose antiobiotique, procede pour le preparer et compositions le contenant.

Info

Publication number
BE901411A
BE901411A BE0/214265A BE214265A BE901411A BE 901411 A BE901411 A BE 901411A BE 0/214265 A BE0/214265 A BE 0/214265A BE 214265 A BE214265 A BE 214265A BE 901411 A BE901411 A BE 901411A
Authority
BE
Belgium
Prior art keywords
same
preparing
compound
antiobiotic
compositions containing
Prior art date
Application number
BE0/214265A
Other languages
English (en)
French (fr)
Inventor
M L A Marvola
E V Marttila
J A Uotila
A K Pippuri
P J Jairisalo
E J Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of BE901411A publication Critical patent/BE901411A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
BE0/214265A 1984-01-06 1984-12-28 Compose antiobiotique, procede pour le preparer et compositions le contenant. BE901411A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
BE901411A true BE901411A (fr) 1985-04-16

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214265A BE901411A (fr) 1984-01-06 1984-12-28 Compose antiobiotique, procede pour le preparer et compositions le contenant.

Country Status (38)

Country Link
US (1) US4599326A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS60158197A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR900006237B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT386414B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU565688B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE901411A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG43189A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1224461A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH666275A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS247191B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1462A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3500179A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK149776C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8605818A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI77249C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2557878B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2152502B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK11590A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU196221B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE57967B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL73885A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS2968A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1184304B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KE (1) KE3841A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU85721A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA20316A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX156277A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8403979A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO160263C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ210606A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH22471A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL144349B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT79777B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO91262B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE461854B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1410866A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU44485B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA8410143B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル, インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US20050163850A1 (en) * 2003-10-31 2005-07-28 Wong Patrick S. Administration of levodopa and carbidopa
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
EP2158920A1 (en) 2006-06-23 2010-03-03 Aegis Therapeutics LLC Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
KR102512178B1 (ko) 2011-05-18 2023-03-20 메더리스 다이어비티즈, 엘엘씨 개선된 펩티드 제약
CN118324870A (zh) 2012-11-20 2024-07-12 梅德瑞斯糖尿病有限责任公司 用于胰岛素抗性的改良的肽药物
CA3157899A1 (en) 2012-11-20 2014-05-30 Mederis Diabetes, Llc Improved peptide pharmaceuticals
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
CN117582516A (zh) 2014-05-28 2024-02-23 梅德瑞斯糖尿病有限责任公司 针对胰岛素抵抗的改良肽药物
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
EP3624840A4 (en) * 2017-05-19 2021-03-10 Lunella Biotech, Inc. ANTIMITOSCINE: TARGETED INHIBITORS OF MITOCHONDRIAL BIOGENESIS TO DESCRIBE CANCER STEM CELLS
CA3083487A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
GB2600026B (en) 2018-02-06 2022-10-12 Aegis Therapeutics Llc Intranasal epinephrine formulations and methods for the treatment of disease
WO2020131696A1 (en) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Triple combination therapies for targeting mitochondria and killing cancer stem cells
KR20210104830A (ko) * 2018-12-17 2021-08-25 루넬라 바이오테크 인코포레이티드 항노화를 위한 삼중 조합 요법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2557878A1 (fr) 1985-07-12
PL251457A1 (en) 1985-11-05
IL73885A (en) 1988-10-31
IT1184304B (it) 1987-10-28
CA1224461A (en) 1987-07-21
PH22471A (en) 1988-09-12
AT386414B (de) 1988-08-25
RO91262B (ro) 1987-07-01
DE3500179C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-08-24
PT79777B (en) 1986-10-21
SE8406671D0 (sv) 1984-12-28
CH666275A5 (de) 1988-07-15
LU85721A1 (fr) 1985-07-24
SU1410866A3 (ru) 1988-07-15
DE3500179A1 (de) 1985-07-18
FR2557878B1 (fr) 1988-01-15
IT8519012A0 (it) 1985-01-04
DK5884D0 (da) 1984-01-06
YU2085A (en) 1987-12-31
NO160263C (no) 1989-03-29
NO850007L (no) 1985-07-08
SE8406671L (sv) 1985-07-07
GB2152502A (en) 1985-08-07
YU44485B (en) 1990-08-31
CY1462A (en) 1989-07-21
FI77249B (fi) 1988-10-31
KR900006237B1 (ko) 1990-08-27
RO91262A (ro) 1987-06-30
IL73885A0 (en) 1985-03-31
ATA985A (de) 1988-01-15
HU196221B (en) 1988-10-28
NZ210606A (en) 1987-08-31
ZA8410143B (en) 1985-08-28
MX156277A (es) 1988-08-04
FI77249C (fi) 1989-02-10
MA20316A1 (fr) 1985-10-01
IE57967B1 (en) 1993-06-02
FI850023A0 (fi) 1985-01-03
NL8403979A (nl) 1985-08-01
PL144349B1 (en) 1988-05-31
DK149776C (da) 1987-04-21
FI850023L (fi) 1985-07-07
AU3705984A (en) 1985-07-11
KR850005452A (ko) 1985-08-26
HUT37628A (en) 1986-01-23
HK11590A (en) 1990-02-23
GB2152502B (en) 1987-10-07
KE3841A (en) 1989-04-07
IE850022L (en) 1985-07-06
DK149776B (da) 1986-09-29
PT79777A (en) 1985-01-01
JPH029040B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-02-28
ES8605818A1 (es) 1986-04-01
BG43189A3 (en) 1988-04-15
DK5884A (da) 1985-07-07
GB8432368D0 (en) 1985-02-06
AU565688B2 (en) 1987-09-24
CS247191B2 (en) 1986-12-18
JPS60158197A (ja) 1985-08-19
NO160263B (no) 1988-12-19
SE461854B (sv) 1990-04-02
US4599326A (en) 1986-07-08
IS2968A7 (is) 1985-04-03
ES539349A0 (es) 1986-04-01

Similar Documents

Publication Publication Date Title
BE901411A (fr) Compose antiobiotique, procede pour le preparer et compositions le contenant.
KR840000528A (ko) 비스-트리아졸 유도체의 제조방법
FR2504535B1 (fr) Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine
CA2096833A1 (fr) Procede de preparation de derives de taxane, nouveaux derives obtenus et compositions pharmaceutiques qui les contiennent
HUT53076A (en) Process for producing tetrahydro-1-benz(c,d)indolepropionic acid sulfonamide derivatives and pharmaceutical compositions comprising such compounds
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
KR850006386A (ko) 아졸류의 제조방법
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
KR840007579A (ko) 신규 니트로 알리파틱화합물의 제조방법
KR890008156A (ko) 깅콜리드의 신규 알콜시 유도체, 그 제조 방법 및 이를 함유한 치료 조성물
GB1448781A (en) N- omega-amino- alkylaniline compounds
GB1357929A (en) 2-phenyl-3-acylbenzothiazolines and their oxides
GB1513168A (en) Bisazomethine metal complex colourants of hydroxy-coumarin derivatives or hydroxy-chromone derivatives and process for their manufacture
GB1325296A (en) Mycophenolic acid glucuronide and a process for the preparation thereof
BE904588A (fr) (-)-1Beta-ETHYL-1ALPHA-HYDROXYMETHYL-1,2,3,4,6,7,12,12beta alpha-OCTAHYDROINDOLO (2,3-a) QUINOLIZINE, PROCEDE POUR LA PREPARER ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CELLE-CI.
KR850003382A (ko) 디아릴인단-1,3-디온의 제조방법
GB1360164A (en) 3,5-dialkyl-4-hydroxyphenylalkanoic acid esters of hydroxyalkyl hydroxyalkanoates
DE3581569D1 (de) Monobasische disobutamidderivate.
IE34307B1 (en) New 1-alkyl-6-azauracil compounds and preparations which contain a 1-alkyl-6-azauracil compound as an active ingredient
NO860114L (no) Imidazolderivater og fremgangsmaate til fremstilling derav.
GB1436982A (en) Imidazole derivatives and process for preparing them
KR840004720A (ko) 살충제 조성물 및 이의 제조방법
GB1310779A (en) N-pyridylalkyl-beta-alkoxy-beta-trifluoromethylphenalkylamines
KR880001635A (ko) 5-플루오로우라실 유도체, 그의 제조방법 및 용도
GB1425729A (en) 1,4-dihydropyridine compounds

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ORION-YHTYMA OY

Effective date: 19931231